Current Research: Among retatrutide predecessors are Tirzepatide (Mounjaro), a GLP-1/GIP dual receptor co-agonist; Liraglutide (Victoza, Saxenda), Exenatide (Byetta), Semaglutide (Ozempic, Rybelsus, Wegovy), Lixisenatide (Adlyxin), and Dulaglutide ( Trulicity), which are GLP-1 receptor agonists. Survodutide is a Glucagon/GLP-1 dual receptor co-agonist. 

Triple power oral tirzepatide GLP-1 Peptides are customized by adding methylated forms of Thiamin, Pyridoxine, NAD+, L-Carnitine, and vitamin B12 to help enhance insulin sensitivity.  Manufactured with approved DMF according to the Federal Food, Drug, and Cosmetic Act, to help to improve energy levels, boost metabolism and help burn fat, improve fatigue, muscle loss, or neuropathy—common concerns during weight loss or diabetes treatment—and may offer metabolic, neurological, and musculoskeletal benefits.

Our peptides API formulations are FDA registered and not affiliated, endorsed, or intended to replace Eli Lilly, Novo Nordisk, or other companies' FDA-approved brands such as Victoza, Saxenda, Byetta, Ozempic, Rybelsus, Wegovy, Adlyxin, Trulicity, or Mounjaro.

Please do not add this item to the shopping cart, as it is contract-manufactured upon order. Contact us for minimum quantity, bulk pricing, or packaging inquiries. MQTY runs from 140,000 to 1.64MM counts.